Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joohee Sul

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology|August 26, 2011
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic gliomaTeri N Kreisl, Weiting Zhang, Yazmin Odia, et al.
Journal of Neuro-Oncology|December 9, 2015
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomasYazmin Odia, Fabio M Iwamoto, Argirios Moustakas, et al.
Plos One|August 14, 2013
Chemoirradiation for glioblastoma multiforme: the national cancer institute experienceJennifer Ho, John Ondos, Holly Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastomaJennifer L Clarke, Fabio M Iwamoto, Joohee Sul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working GroupNancy U Lin, Tatiana Prowell, Antoinette R Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiformeJohn K Park, Tiffany Hodges, Leopold Arko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology DrugsPaul G Kluetz, Patricia Keegan, George D Demetri, et al.
The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.
Neuro-Oncology|September 26, 2015
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A Levin, Peter J Tonge, James M Gallo, et al.
Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology|August 26, 2011
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic gliomaTeri N Kreisl, Weiting Zhang, Yazmin Odia, et al.
Journal of Neuro-Oncology|December 9, 2015
A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomasYazmin Odia, Fabio M Iwamoto, Argirios Moustakas, et al.
Plos One|August 14, 2013
Chemoirradiation for glioblastoma multiforme: the national cancer institute experienceJennifer Ho, John Ondos, Holly Ning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2009
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastomaJennifer L Clarke, Fabio M Iwamoto, Joohee Sul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working GroupNancy U Lin, Tatiana Prowell, Antoinette R Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiformeJohn K Park, Tiffany Hodges, Leopold Arko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology DrugsPaul G Kluetz, Patricia Keegan, George D Demetri, et al.
The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.
Neuro-Oncology|September 26, 2015
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A Levin, Peter J Tonge, James M Gallo, et al.
Neuro-Oncology|January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q Lee, Michael Weller, Joohee Sul, et al.
Pageof 2